Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
XTLB
#8920
XTL Biopharmaceuticals Ltd. American Depositary Shares
0.600
0
USD
-4.76%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
-4.76%
Monatliche Änderung
-33.18%
6 month change
-33.18%
Jahresänderung
-33.18%
Vorheriger Schlusskurs
0.630
0
Open
0.600
0
Bid
0.600
0
Ask
0.603
0
Low
0.600
0
High
0.600
0
Volumen
1
Märkte
Aktien
Gesundheitswesen
XTLB
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
220.35 M
629.03 M
Valuation ratios
Enterprise value
446.38 M
1.13 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Nachrichten
XTL Biopharmaceuticals droht Delisting von der NASDAQ
XTL Biopharmaceuticals droht NASDAQ-Delisting – Aktie fällt deutlich
XTL Biopharmaceuticals faces Nasdaq delisting notice
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice
XTL Biopharmaceuticals: Aktionäre stimmen Kapitalerhöhung und Privatplatzierung zu
XTL Biopharmaceuticals shareholders approve share capital increase and private placement
Gericht ordnet Liquidation von XTL-Tochtergesellschaft Social Proxy an
XTL Biopharmaceuticals subsidiary Social Proxy enters liquidation following court order
XTL Biopharmaceuticals: Übernahme und Privatplatzierung sollen NASDAQ-Listingregeln sichern
XTL Biopharmaceuticals moves forward with NeuroNOS acquisition and plans private placement
Tochtergesellschaft von XTL Biopharmaceuticals stellt Insolvenzantrag in Israel
XTL Biopharmaceuticals subsidiary files for insolvency in Israeli court